Coloplast Corp., Hollister Incorporateda and ConvaTec Group PLC are Dominating the Global Ostomy Devices Market in 2018

Global Ostomy Devices Market is expected to grow at a substantial CAGR of 6.6% in the forecast period of 2019 to 2026. The years considered for study are as mentioned below:

Access Full Report at https://www.databridgemarketresearch.com/reports/global-ostomy-devices-market

The global ostomy devices market is a fragmented market which includes key players and local players. The market is growing owing to the favourable market scenario. The market has a prominent growth in upcoming years due to increasing prevalence of bladder cancer, bowel cancer and inflammatory bowel diseases and favourable reimbursement policies for ostomy devices.

The market has witnessed developments in terms of merger and acquisitions or product launches to enhance the product portfolio to meet the rising demand. For instance, In January 2018, Coloplast Corp acquired SAS Lilia a distributer of primarily catheter and ostomy in France. The acquisition will help the company to protect innovative products and services for end users and to strengthen position and product offering in France. Furthermore, the acquisition will help company to work closely with channel partners and healthcare professionals intended to improve overall end user outcomes.

Coloplast Corp. has dominated the global ostomy devices market. The other key players existing in the market includes Hollister Incorporated, ConvaTec Group PLC, Salts Healthcare, B. Braun Melsungen AG, 3M, ALCARE Co., Ltd., Flexicare (Group) Limited, Henkel AG & Co. KGaA, Marlen Manufacturing & Development Company, Nu-Hope Laboratories, Inc., OxMed International GmbH, Smith & Nephew, Torbot Group, Inc., Welland Medical Limited among others.

Coloplast Corp

Coloplast Corp. headquartered in Humlebaek, Denmark was founded in 1954. The company focuses on providing products and services to fulfil customer’s requirement. The company operates through four business segments which include ostomy care, continence care, interventional urology, wound & skin care in which ostomy care is the market focused segment. The product categories of the company include ostomy care, bladder & bowel, wound care, skin care, interventional urology in which ostomy care is market focused category. The company has approx. 11,738 employees as of September 30, 2018.

  • In July 2019, Coloplast Corp. launched SenSura Mio Baby and SenSura Mio Kids in SenSura Mio family. The products are designed for babies and kids ostomy care. The product launch will help the company to provide extensive product portfolio in ostomy care.

The company has global networks through direct sales representatives and distributors in Asia-Pacific, Europe, Middle East and Africa, South America, North America. Its subsidiaries are Coloplast Manufacturing US LLC (U.S.), Coloplast Corp. (U.S.), Comfort Medical, LLC (U.S.), Coloplast Hungary Kft (Hungary) among others.

Hollister Incorporated

Hollister Incorporated headquartered in Illinois, U.S was founded in 1921. The company focuses on development & manufacturing of the advanced medical products for ostomy care to ostomy patients and healthcare professionals. The company is providing products in ostomy care products, continence care products, wound care products, critical care products categories. The market focus category lies under ostomy care products category.

  • In December 2018, Hollister Incorporated got Innovative Technology Designation from Vizient, Inc. a largest member-driven, health care performance improvement company for its CeraPlus skin barriers, ceramide infused products and Adapt CeraRing barrier rings. This designation led the ceramide infused products more rewarding and dignified for the Ostomy Care Services.

It has its global networks through direct sales representatives and distributors in Europe, North America, and Asia-Pacific.

ConvaTec Group PLC

ConvaTec Group PLC headquartered in Berkshire, U.K. was founded in 1978. The company is focusing on providing products and technologies for various therapy managements such as chronic conditions, advanced wound care, ostomy care, continence and critical care and infusion devices.

The company operates through four business segments which include advanced wound care, ostomy care, continence & critical care, infusion devices in which ostomy care is the market focused segment. The product categories of the company include ostomy, wound & skin, continence & critical care, infusion care in which ostomy is market focused category. The company has approx. 9,413 employees as of December 31, 2018.

  • In January 2017, Convatec Group Plc has acquired EuroTec a Netherlands-based manufactures and distributes one- and twopiece ostomy systems and accessories through various distribution channels in the Netherlands and Belgium. The acquisition will help the company to significantly strengthen ostomy care business in Benelux and the France region.

It has its global networks through subsidiaries in Asia-Pacific, Europe, Middle East and Africa, South America, North America. Its subsidiaries are Boston Medical Device International, LLC (U.S.), ConvaTec Healthcare B Sarl (China), UnomedicalA/S (Denmark), WPI Holdings Inc. (U.S.), 180 Medical (U.S.) among others.